blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1909799

EP1909799 - ORAL CONTRACEPTION WITH TRIMEGESTONE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.06.2013
Database last updated on 14.06.2024
Most recent event   Tooltip28.06.2013Application deemed to be withdrawnpublished on 31.07.2013  [2013/31]
Applicant(s)For all designated states
Grünenthal GmbH
Zieglerstrasse 6
52078 Aachen / DE
[2008/16]
Inventor(s)01 / GLOGER, Oliver
Egestorffstr. 25 D
12307 Berlin / DE
02 / KUGELMANN, Heinrich
Blücherplatz 7
52068 Aachen / DE
03 / POPOVA, Maria
Schraungracht 12
52076 Aachen / DE
04 / Tamara PFAFF
Friedenstrasse 21
D- 40219 Düsseldorf / DE
 [2008/43]
Former [2008/16]01 / GLOGER, Oliver
Egestorffstr. 25 D
12307 Berlin / DE
02 / KUGELMANN, Heinrich
Blücherplatz 7
52068 Aachen / DE
03 / POPOVA, Maria
Schraungracht 12
52076 Aachen / DE
Representative(s)Bülle, Jan
Kutzenberger Wolff & Partner
Waidmarkt 11
50676 Köln / DE
[N/P]
Former [2008/16]Bülle, Jan
Kutzenberger & Wolff Patentanwaltssozietät Theodor-Heuss-Ring 23
50668 Köln / DE
Application number, filing date06762699.419.07.2006
[2008/16]
WO2006EP07103
Priority number, dateDE2005103449820.07.2005         Original published format: DE102005034498
US2006034854506.02.2006         Original published format: US 348545
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007009769
Date:25.01.2007
Language:EN
[2007/04]
Type: A1 Application with search report 
No.:EP1909799
Date:16.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 25.01.2007 takes the place of the publication of the European patent application.
[2008/16]
Search report(s)International search report - published on:EP25.01.2007
ClassificationIPC:A61K31/575, A61K31/565, A61P15/18
[2008/16]
CPC:
A61K31/565 (EP,KR); A61K31/575 (EP,KR); A61P15/18 (EP)
C-Set:
A61K31/565, A61K2300/00 (EP);
A61K31/575, A61K2300/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/16]
Extension statesHR20.02.2008
TitleGerman:ORALE KONTRAZEPTION MIT TRIMEGESTON[2008/16]
English:ORAL CONTRACEPTION WITH TRIMEGESTONE[2008/16]
French:CONTRACEPTION ORALE A L'AIDE DE TRIMEGESTONE[2008/16]
Entry into regional phase20.02.2008National basic fee paid 
20.02.2008Designation fee(s) paid 
20.02.2008Examination fee paid 
Examination procedure18.05.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.02.2008Examination requested  [2008/16]
01.02.2013Application deemed to be withdrawn, date of legal effect  [2013/31]
07.03.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/31]
Fees paidRenewal fee
14.07.2008Renewal fee patent year 03
10.07.2009Renewal fee patent year 04
14.07.2010Renewal fee patent year 05
12.07.2011Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.07.201207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XDY]FR2801218  (HOECHST MARION ROUSSEL INC [FR]) [XD] 1-20 * page 2, lines 32-38 * * page 8, lines 27-35 * * examples 4,6 * [Y] 1-20;
 [XDY]WO9804246  (AMERICAN HOME PROD [US]) [XD] 1-20 * claims 1,8 * [Y] 1-20;
 [X]  - SHIRK REBECCA A ET AL, "Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.", THE JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. MAR 2005, (200503), vol. 94, no. 4, ISSN 0960-0760, pages 361 - 368, XP009073861 [X] 10-14,16 * page 362, column 2, paragraph 2 * * figure 2 *

DOI:   http://dx.doi.org/10.1016/j.jsbmb.2004.12.026
 [YD]  - SCHINDLER ADOLF E ET AL, "Classification and pharmacology of progestins.", MATURITAS, (20031210), vol. 46, no. Suppl. 1, ISSN 0378-5122, pages S7 - S16, XP002404629 [YD] 1-20 * page S14; table 3 *

DOI:   http://dx.doi.org/10.1016/j.maturitas.2003.09.014
 [A]  - WINNEKER R C ET AL, "The preclinical biology of a new potent and selective progestin: trimegestone", STEROIDS, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, NY, US, (200311), vol. 68, no. 10-13, ISSN 0039-128X, pages 915 - 920, XP004479940 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0039-128X(03)00142-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.